Strongbridge Biopharma plc
SBBP · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45 | -$49 | $32 | -$113 |
| Dep. & Amort. | $5 | $5 | $7 | $5 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $7 | $9 | $8 | $5 |
| Change in WC | $12 | -$56 | $67 | -$3 |
| Other Non-Cash | -$18 | $47 | -$198 | $59 |
| Operating Cash Flow | -$38 | -$45 | -$85 | -$45 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | $0 |
| Net Acquisitions | $0 | $0 | $135 | $0 |
| Inv. Purchases | $0 | -$56 | $0 | $0 |
| Inv. Sales/Matur. | $21 | $36 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | -$8 |
| Investing Cash Flow | $21 | -$21 | $134 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $29 | $0 | $64 | $26 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $48 | $0 | $15 | $44 |
| Financing Cash Flow | $48 | $0 | $15 | $44 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $30 | -$65 | $65 | -$9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57 | $122 | $58 | $67 |
| End Cash | $88 | $57 | $122 | $58 |
| Free Cash Flow | -$38 | -$45 | -$85 | -$45 |